InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Baylis, Frank. Director active across 1 company, notably Profound Medical Corp.. Aggregated, 4 filings have been logged. History available since 11 June 2026. The latest transaction was filed on 11 June 2026 (50 - Grant of options). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Frank Baylis is a declarant linked to Profound Medical Corp., where he is listed as 4 - Director of Issuer. The record shows 4 filings in total, all in the recent sample, with buy and sell volumes of EUR 0 and a date range from 2026-06-15 to 2026-06-15; the most frequent transaction nature is 00 - Opening Balance-Initial SEDI Report.